Relocates requirements that the board of pharmacy must comply with when adopting interim rules declaring a substance a synthetic drug from the professional licensing law to the statutes governing administrative rulemaking. Makes certain changes to the lists of controlled substances.

Statutes affected:
Introduced House Bill (H): 4-22-2.3-8, 25-26-13-4.1, 35-48-2-4, 35-48-2-6, 35-48-2-10
House Bill (H): 4-22-2.3-8, 25-26-13-4.1, 35-48-2-4, 35-48-2-6, 35-48-2-10
House Bill (S): 4-22-2.3-8, 25-26-13-4.1, 25-26-13-31.2, 35-48-2-4, 35-48-2-6, 35-48-2-10
Engrossed House Bill (S): 4-22-2.3-8, 25-26-13-4.1, 35-48-2-4, 35-48-2-6, 35-48-2-10, 25-26-13-31.2
Enrolled House Bill (H): 4-22-2.3-8, 25-26-13-4.1, 35-48-2-4, 35-48-2-6, 35-48-2-10